We recently discovered that CAFs enhance oxaliplatin resistance in pancreatic cancer cells by promoting IL-8-driven transactivation of lncRNA UPK1A-AS1, which subsequently increases the efficiency of NHEJ repair of DNA damage [13]. This evidence concerns the gene UPK1A and pancreatic neoplasm.